Nicole Sweeny Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity

Nicole Sweeny is Chief Commercial Officer of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 39,728 shares of KALV, which is worth approximately $529,176. The most recent transaction as insider was on Nov 24, 2025, when has been sold 3,813 shares (Common Stock) at a price of $13.45 per share, resulting in proceeds of $51,284. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.7K

23.03% 3M change

n/a 12M change

Total Value Held $529,176

Nicole Sweeny Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 24 2025	SELL Open market or private sale	$51,284 $13.45 p/Share	3,813 Reduced 8.76%	39,728 Common Stock
Nov 22 2025	BUY Exercise of conversion of derivative security	-	5,000 Added 10.3%	43,541 Common Stock
Nov 21 2025	BUY Exercise of conversion of derivative security	-	6,250 Added 13.95%	38,541 Common Stock
Aug 25 2025	SELL Open market or private sale	$19,861 $13.42 p/Share	1,480 Reduced 4.38%	32,291 Common Stock
Aug 22 2025	SELL Open market or private sale	$24,642 $13.22 p/Share	1,864 Reduced 6.08%	28,771 Common Stock
Aug 22 2025	BUY Exercise of conversion of derivative security	-	5,000 Added 12.9%	33,771 Common Stock
Aug 21 2025	BUY Exercise of conversion of derivative security	-	6,250 Added 16.94%	30,635 Common Stock

Also insider at

PRAX

Praxis Precision Medicines, Inc. Healthcare

Chief Commercial Officer

Nicole Sweeny

Chief Commercial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Value

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

Operation

Value

Type

News

Receive news related to KalVista Pharmaceuticals, Inc.

Track Activities on KALV

Account